Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|March 15, 2001
Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndromeM L Bertolaccini, T Atsumi, J S Lanchbury, et al.
Blood|May 20, 2004
Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal deathVerónica Hurtado, Ramón Montes, Jean-Christophe Gris, et al.
Cephalalgia : an International Journal of Headache|July 16, 2008
Migraine and antiphospholipid antibodies: no association found in migraine-discordant monozygotic twinsF M K Williams, L F Cherkas, M L Bertolaccini, et al.
Critical Reviews in Oncology/Hematology|January 10, 2020
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelinesF Passiglia, S Pilotto, F Facchinetti, et al.
Critical Reviews in Oncology/Hematology|February 17, 2020
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelinesF Passiglia, L Bertolaccini, M Del Re, et al.
Journal of Lipid Research|February 4, 2003
Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigenKazuko Kobayashi, Makoto Kishi, Tatsuya Atsumi, et al.
Annals of the Rheumatic Diseases|November 18, 2004
Association of HLA-DM polymorphism with the production of antiphospholipid antibodiesM L Sanchez, K Katsumata, T Atsumi, et al.
The Lancet. Haematology|August 30, 2016
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trialHannah Cohen, Beverley J Hunt, Maria Efthymiou, et al.
Lupus|February 10, 2011
'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010M L Bertolaccini, O Amengual, T Atsumi, et al.
Rheumatology (Oxford, England)|October 8, 2013
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)Maria J Cuadrado, Maria L Bertolaccini, Paul T Seed, et al.
Pageof 6